EMIS

 
Common Stock SEC Reporting - Current
Pink Current Information
Contact Info
  • 4 Becker Farm Road
  • Suite 103
  • Roseland, NJ 07068

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000805326
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1986
Employees Not Available
Company Officers/Contacts
Alan L. Rubino CEO, President
Alan Gallantar Interim CFO
Phil Nikolayuk Finance Manager
Company Directors
Tim Rothwell Chairman
John Harkey
Timothy McInerney
Jacob M. Plotsker
Mark Rachescky
Alan L. Rubino
Michael Weiser
Service Providers
Accounting/Auditing Firm
RSM US LLP
1400 Post Oak Blvd.
Suite 900
77056
 
Securities Counsel
Lowenstein Sandler PC
1251 Avenue of the Americas
New York, NY, 10021
United States
 
Investor Relations Firm
Argot Partners
200 Park Avenue South
Suite 1515
New York, NY, 10003
United States
 
Company History
  • Formerly=Clinical Technologies Associates, Inc. to 1-92
EMIS Security Details
Share Structure
Market Value1 $27,916,240 a/o Mar 23, 2017
Authorized Shares 400,000,000 a/o Jun 13, 2016
Outstanding Shares 60,687,478 a/o Jun 13, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 46,144,726 a/o Jun 13, 2016
Par Value 0.01
Shareholders
Shareholders of Record 192 a/o Mar 29, 2016
Short Selling Data
Short Interest 11,849 (-3.82%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security